Evidence map›Paper›PMID 21606603›Full record

ArticleThe Journal of clinical investigation2011

Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link?

David S Wilkes

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Airway hypoxia in lung transplantation.Current opinion in physiology · 2019
    Article
  7. Article
  8. Hypoxia-Inducible Factor-1α Regulates CD55 in Airway Epithelium.American journal of respiratory cell and molecular biology · 2016
    Article
  9. Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.American journal of respiratory and critical care medicine · 2016
    Article
  10. Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2016
    Review
  11. Review
  12. IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

David S WilkesCenter for Immunobiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. dwilkes@iupui.edu
Indiana University – Purdue University Indianapolis · US

Funding

Transgenic Mouse CoreP01AI084853 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI WILKES, DAVID S · 2010 to 2014
$7.7M
IMMUNE RESPONSES IN LUNG ALLOGRAFT REJECTIONR01HL060797 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WILKES, DAVID S · 1999 to 2006
$2.2M
NHLBI NIH HHS R01 HL060797NHLBI NIH HHS R01HL60797NIAID NIH HHS P01 AI084853NIAID NIH HHS P01AI084853PHS HHS R01096845
6 · The paper itself

Abstract

Chronic lung allograft rejection, known as obliterative bronchiolitis (OB), is the leading cause of death in lung transplant patients. Although OB pathogenesis is not fully understood, in this issue of the JCI, Jiang and colleagues report that tissue hypoxia resulting in dysfunctional airway microvasculature precedes the airway fibrosis characteristic of OB. In addition, a relative deficiency of allograft endothelial cell-derived HIF-1α contributes to this process. Data showing that overexpressing HIF-1α restores the microvascular airway normoxia and prevents airway fibrosis highlight a novel role for vascular biology in OB pathogenesis.

Indexed as

AnimalsBronchial ArteriesBronchiolitis ObliteransCalcineurin InhibitorsCell HypoxiaChronic DiseaseEpithelial CellsEpithelial-Mesenchymal TransitionFibrosisForecastingGenetic TherapyGraft RejectionHumansHypoxia-Inducible Factor 1, alpha SubunitImmunosuppressive AgentsIschemiaCalcineurin InhibitorsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitImmunosuppressive Agents

Identifiers

PMID21606603
PMCPMC3104786
OpenAlexW2035723868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.